전기영동 시장 예측(-2030년) : 제품, 용도, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Electrophoresis Market is accounted for $3.1 billion in 2023 and is expected to reach $5.21 billion by 2030 growing at a CAGR of 7.7% during the forecast period. Proteins and nucleic acids can be separated using an approach called electrophoresis. The primary uses of electrophoresis supplies and equipment are in the analysis of DNA and RNA. Additionally, it is employed in biochemistry to separate molecules according to their charge, size, or affinity. And it is used to separate proteins according to factors such as size, purity, and density. This technique's ease of use makes it useful for a number of tasks, including vaccine analysis, antibody analysis, hemoglobinopathies diagnosis, and drug quality control.

According to PharmaTimes December 2018, 13.5 bn USD venture capital was invested into the biotechnology sector in the first ten months of 2018, beating the previous full-year record of USD 11 bn in 2017.

Market Dynamics:

Driver:

Research in biotechnology and life sciences

In biotechnology and life sciences research, electrophoresis is essential for genomic sequencing. It allows DNA fragments to be separated for analysis and opens the door for advancements in next-generation sequencing methods. Furthermore, it is essential for proteomic profiling, which aids in the understanding of diseases, drug development, and biomarker discovery. All of these areas have a greater need for sophisticated electrophoresis systems.

Restraint:

Complexity and necessary skill set

The complicated nature of the procedures involved in electrophoresis is one of the major obstacles in the field. Accurate experiment setup and execution in electrophoresis demand a certain level of skill. Moreover, researchers without specialized training may find it difficult to interpret the results and troubleshoot any issues, which can limit their accessibility.

Opportunity:

Improvements in high-throughput electrophoresis technology

There is a strong market for high-throughput electrophoresis systems, particularly in areas like proteomics and genomics. Additionally, researcher opportunities can be greatly increased by the development of faster and more efficient systems, which will make it possible to analyze larger sample sets in less time. Increased adoption in academic research, pharmaceuticals, and clinical diagnostics may result from this.

Threat:

Expensive and scarce resources

The issue of affordability faces the electrophoresis market. Due to the high initial cost of electrophoresis equipment, power supplies, and consumables like gels and buffers, smaller research labs and environments with limited resources may not be able to use them. Moreover, to remain competitive, manufacturers must innovate and develop more affordable solutions because the continuous need for consumables raises the overall cost.

COVID-19 Impact:

The market for electrophoresis was greatly affected by the COVID-19 pandemic. The global supply chain was disrupted, which affected the availability of consumables and equipment for electrophoresis. However, it also brought attention to the crucial role that technology plays in the development of diagnostic tests, especially in the quick creation and validation of tests like PCR assays. Furthermore, in the context of international health emergencies, the pandemic highlighted the value of electrophoresis in vaccine research and the study of infectious diseases, opening up new business prospects for the industry.

The Electrophoresis Software segment is expected to be the largest during the forecast period

Over the course of the forecast period, electrophoresis software is expected to hold the largest share in the electrophoresis market. In the big data era, these software solutions are essential for managing, interpreting, and analyzing data from electrophoresis results. They improve the effectiveness of research and diagnostics by guaranteeing precise and repeatable results, which is especially useful in genomics, proteomics, and clinical applications. Moreover, electrophoresis software is becoming a central and increasingly important part of the electrophoresis market because of its capacity to automate data handling and offer insightful information.

The Pharmaceutical & Biotechnology Companies segment is expected to have the highest CAGR during the forecast period

In the electrophoresis market, the Pharmaceutical & Biotechnology Companies segment is projected to have the highest CAGR. These businesses constantly drive demand for electrophoresis services and equipment because they use electrophoresis for a variety of purposes, such as biologics analysis, quality control, and drug development. Additionally, the robust and steady growth seen in this market is partly due to the increased focus on biopharmaceuticals and the requirement for accurate characterization of complex biomolecules. Due to their leadership in research and development, pharmaceutical and biotechnology companies are a major force behind innovation and market expansion in the electrophoresis sector.

Region with largest share:

In the global electrophoresis market, North America holds the largest share. Numerous factors, including a robust healthcare system, large investments in R&D, a high rate of chronic illnesses, and a large concentration of biotechnology and pharmaceutical companies, are responsible for this dominance. Moreover, the substantial market share of the region can be attributed to its strong academic and research institutions, as well as its emphasis on technological advancements. North America's leadership in the electrophoresis market is further cemented by its proactive adoption of cutting-edge techniques and strict regulatory requirements.

Region with highest CAGR:

In the global electrophoresis market, Asia-Pacific is growing at the highest CAGR. Numerous factors, including the growing biotechnology and pharmaceutical industries, more R&D being done, an increasing emphasis on precision medicine, and an increase in academic and research institutions, are contributing to this rapid growth. Additionally, the strong market expansion is also attributed to the region's expanding healthcare infrastructure and the demand for cutting-edge diagnostic technologies. As a result, Asia-Pacific is growing significantly and is becoming a more significant player in the electrophoresis market.

Key players in the market

Some of the key players in Electrophoresis market include: Cleaver Scientific Ltd., Analytik Jena GMBH, Lumex Instruments , Beckman Coulter, Agilent Technologies, Inc., QIAGEN N.V., Sebia Group, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Hoefer, Inc. (Harvard Biosciences), Danaher Corporation, Merck & Co. Inc., Takara Bio, Inc., AES life sciences, Helena Laboratories Corporation, PerkinElmer Inc., SERVA Electrophoresis GmbH, Lonza Group and Shimadzu Corporation.

Key Developments:

In August 2023, Collaboration between Beckman Coulter and Fujirebio is expected to lead to multiple new tests for neurodegenerative diseases, including Alzheimer's. The new collaboration, which was announced last month, builds on the supplier relationship between the two companies that has existed for more than 20 years, said Monte Wiltse, president and CEO of Fujirebio Diagnostics.

In April2023, Ohio Lumex Signs Agreement With Mississippi Lime Company (MLC) to Take Over Customer and Technical Services for Breen. MLC grants license to Ohio Lumex to sell and service Breen sulfuric acid dewpoint monitoring technologies. Mississippi Lime Company (MLC), a leading global supplier of high-calcium lime products and technical solutions, has completed an agreement to transfer customer and technical services for its Breen Energy Solutions subsidiary to Ohio Lumex.

In March 2023, Agilent Technologies Inc. today announced a multi-year distribution agreement with Proscia® a leader in digital pathology - to offer a comprehensive digital diagnostic pathology system. Combining Agilent's trusted pathology staining solutions with Proscia's Concentriq® Dx enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality to improve patient health outcomes.

Products Covered:

• Electrophoresis Reagents
• Electrophoresis Systems
• Gel Documentation Systems
• Electrophoresis Software
• Other Products

Applications Covered:

• Research Applications
• Diagnostics Applications
• Quality Control & Process Validation
• Other Applications

End Users Covered:

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centers
• CROs and CMOs
• Forensic Laboratories
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Electrophoresis Market, By Product

• 5.1 Introduction
• 5.2 Electrophoresis Reagents
  • 5.2.1 Protein Electrophoresis Reagents
  • 5.2.2 Nucleic Acid Electrophoresis Reagents
• 5.3 Electrophoresis Systems
  • 5.3.1 Gel Electrophoresis Systems
  • 5.3.2 Capillary Electrophoresis Systems
• 5.4 Gel Documentation Systems
• 5.5 Electrophoresis Software
• 5.6 Other Products

6 Global Electrophoresis Market, By Application

• 6.1 Introduction
• 6.2 Research Applications
• 6.3 Diagnostics Applications
• 6.4 Quality Control & Process Validation
• 6.5 Other Applications

7 Global Electrophoresis Market, By End User

• 7.1 Introduction
• 7.2 Academic & Research Institutes
• 7.3 Pharmaceutical & Biotechnology Companies
• 7.4 Hospitals & Diagnostic Centers
• 7.5 CROs and CMOs
• 7.6 Forensic Laboratories
• 7.7 Other End Users

8 Global Electrophoresis Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Cleaver Scientific Ltd.
• 10.2 Analytik Jena GMBH
• 10.3 Lumex Instruments
• 10.4 Beckman Coulter
• 10.5 Agilent Technologies, Inc.
• 10.6 QIAGEN N.V.
• 10.7 Sebia Group
• 10.8 Thermo Fisher Scientific Inc.
• 10.9 Bio-Rad Laboratories, Inc.
• 10.10 Hoefer, Inc. (Harvard Biosciences)
• 10.11 Danaher Corporation
• 10.12 Merck & Co. Inc.
• 10.13 Takara Bio, Inc.
• 10.14 AES life sciences
• 10.15 Helena Laboratories Corporation
• 10.16 PerkinElmer Inc.
• 10.17 SERVA Electrophoresis GmbH
• 10.18 Lonza Group
• 10.19 Shimadzu Corporation